The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis

Shuwen Bai,Wen Dang,Wenying Hong,Wenyu Liao,Robert David Smith
DOI: https://doi.org/10.1186/s12879-024-09103-8
IF: 3.7
2024-02-17
BMC Infectious Diseases
Abstract:Within China, Hepatitis B virus (HBV) infection remains widely prevalent and one of the major public health problems. There have been only two previous estimates of its prevalence at the population level in China, with the latest survey conducted in 2006. A meta-analysis estimated the prevalence of HBV within China between 2013 and 2017 as 7%. This review provides an updated estimate of HBV prevalence in China from 2018 to 2022.
infectious diseases
What problem does this paper attempt to address?